This, when coupled with our effective expense management, resulted in a 35% year-over-year increase in our income from operations to $72.2 million and strong earnings of $1.22 per diluted share.
Accordingly, net income totaled $53.5 million or $1.22 per fully diluted share compared to $39.6 million or $0.88 per fully diluted share.
This, when coupled with our effective expense management, resulted in a 35% year-over-year increase in our income from operations to $72.2 million and strong earnings of $1.22 per diluted share.
Accordingly, net income totaled $53.5 million or $1.22 per fully diluted share compared to $39.6 million or $0.88 per fully diluted share.
We executed a strong second quarter with sales of $326.1 million, improving 7% year-over-year and 15% quarter-over-quarter on higher volume despite the significant level of macroeconomic challenges resulting from COVID-19.
As Karen highlighted, our consolidated sales were strong, increasing 7% to $326.1 million.
Brian will provide additional detail regarding our reinstated financial outlook for the full year of 2020 shortly.
Net sales are estimated to increase in the range of 1.5% to 4% compared to the full year ended December 31, 2019.
Net sales are estimated to increase in the range of 1.5% to 4% compared to the full year ended December 31, 2019.
